Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Transboundary and Emerging Diseases|September 21, 2019
Development and evaluation of swine vesicular disease isotype-specific antibody ELISAs based on recombinant virus-like particlesMing Yang, Kayla Gagliardi, Leanne McIntyre, et al.
The Journal of General Virology|December 11, 2012
Generation and characterization of a new panel of broadly reactive anti-NS1 mAbs for detection of influenza A virusMd Niaz Rahim, Mohammed Selman, Patricia J Sauder, et al.
Msphere|May 22, 2025
Comparative pathogenicity of three A(H5N1) clade 2.3.4.4b HPAI viruses in blue-winged teal and transmission to domestic poultryTamiru N Alkie, Carissa Embury-Hyatt, Anthony V Signore, et al.
Biosensors & Bioelectronics|June 26, 2018
Synchronized electromechanical integration recording of cardiomyocytesNing Hu, Tianxing Wang, Hao Wan, et al.
Scientific Reports|July 2, 2017
0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loopCaixia Xia, Liyan Shui, Guohua Lou, et al.
Conservation Physiology|May 13, 2026
Interannual differences in common eider duck exposure to avian influenza viruses at an Arctic colonyJennifer F Provencher, Andre Morrill, Holly L Hennin, et al.
Molecular Cancer Therapeutics|December 10, 2009
Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of beta-tubulin at Cys 12 and suppression of microtubule dynamicsWanhong Xu, Biao Xi, Jieying Wu, et al.
Viruses|May 28, 2022
Evolutionary Dynamics of Mexican Lineage H5N2 Avian Influenza VirusesWanhong Xu, Roberto Navarro-López, Mario Solis-Hernandez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 8, 2018
First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of ResistanceYuxiang Ma, Xin Zheng, Hongyun Zhao, et al.
Molecular Cancer Therapeutics|August 31, 2016
AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer PatientsXiao Xu, Long Mao, Wanhong Xu, et al.
Pageof 5